Share
News
-
08 April 2011 /News - miscellaneous
No increase in neither suicide attempts nor poisonings with paracetamol in Sweden
Neither the number of poisonings nor suicide attempts with the active substance paracetamol has increased in Sweden, despite the fact that it has become easier to buy paracetamol in Sweden. This is the findings of a study published yesterday by the Swedish Medical Products Agency.
-
24 March 2011 /News - miscellaneous
Danish Pharmacovigilance Update, 17 March 2011
This month’s issue of Danish Pharmacovigilance Update includes articles about reports of serious side effects in Japan from the childhood vaccines Prevenar (PCV7)® and Act-Hib® and reports of serious side effects in France from the childhood vaccine Prevenar13®.
-
18 March 2011 /News - miscellaneous
No need to take potassium iodide in Denmark
The nuclear crisis in Japan does not cause radiation risk in Denmark, and therefore, there is no reason to take potassium iodide if you stay in Denmark.
-
18 February 2011 /News - miscellaneous
Age limit of 18 years introduced for buying painkillers
As of 7 March 2011, young people under the age of 18 will only be allowed to buy painkillers at a pharmacy, and only on prescription from a doctor.
-
08 February 2011 /News - miscellaneous
Medicine and mainstreaming
We invite you to a symposium on medicine and gender mainstreaming Tuesday 22 February 2011 from 15.30 to 17.00 at the Danish Medicines Agency, Axel Heides Gade 1, DK-2300 Copenhagen S.
-
04 January 2011 /News - miscellaneous
Avoid dangerous weight-loss products
The Danish Medicines Agency once again puts focus on the risk of weight-loss products containing the active substances ephedrine, rimonabant and sibutramine - weight-loss products that have not been authorised by the authorities.
-
17 December 2010 /News - miscellaneous
Recommendation for doctors and dialysis patients in connection with peritoneal dialysis solutions from Baxter A/S
The European Medicines Agency (EMA) recommends that all batches of Baxter's peritoneal dialysis solutions, Extraneal®, Nutrineal® and Dianeal® be replaced.
-
16 December 2010 /News - miscellaneous
Moderate catch in fitness centres
The Danish Veterinary and Food Administration and the Danish Medicines Agency only found a small number of violations of the Danish Food Act and the Danish Medicines Act during a joint on-site inspection of some 30 fitness centres and clubs in autumn 2010.
-
12 November 2010 /News - miscellaneous
Heads of Medicines Agencies adopts new strategy
The Heads of Medicines Agencies (HMA) has adopted a new strategy for 2011-2015 at the HMA meeting in Antwerp on 25 October 2010. The key themes of the strategy are.
-
18 October 2010 /News - miscellaneous
Expiry of transitional arrangement for traditional herbal medicinal products and natural medicinal products
Since 2005, it has been possible in Denmark to have traditional herbal medicinal products registered as an alternative way of bringing herbal medicines onto the Danish market.
-
15 September 2010 /News - miscellaneous
Danish authorities focus efforts on fitness centres
Illegal medicines under the counter, unauthorised sale of food supplements in the back? Next week, the Danish Veterinary and Food Administration and the Danish Medicines Agency concentrate their efforts to combat the distribution of illegal food supplements and medicines in fitness centres and fitness clubs across Denmark.
-
09 August 2010 /News - miscellaneous
Danish authorities assess risk of calcium supplements
Do calcium supplements increase the risk of blood clots? Are changes to the official recommendations required? These questions are now being discussed by the Danish Veterinary and Food Administration and the Danish Medicines Agency, etc. after an article in the British Medical Journal (BMJ) suspected calcium supplements of increasing the risk of heart attacks.
-
13 July 2010 /News - miscellaneous
Consultation on the Heads of Medicines Agencies’ Strategy Paper for 2011-2015
The Heads of Medicines Agencies (HMA) has drawn up a draft strategy document for the period 2011-2015. As part of the strategy development process, the HMA now gives its key stakeholder groups an opportunity to comment on the strategy's content.
-
25 March 2010 /News - miscellaneous
Danish Medicines Agency co-organises biosimulation workshop on 11 March 2010
The Danish Medicines Agency co-organises a workshop on biosimulation taking place on Thursdag 11 March 2010 in the city of Lund in Sweden.
-
19 February 2010 /News - miscellaneous
Spot checking of distribution of medical samples for the year 2007
The Danish Medicines Agency performs spot checks of Danish pharmaceutical companies’ distribution of free medical samples for doctors, dentists and veterinarians.
-
26 January 2010 /News - miscellaneous
Vacancy for an Executive Director of the European Medicines Agency
The European Medicines Agency (EMA) is looking for an Executive Director to lead and manage the Agency and take overall responsibility for its operations, thus ensuring achievement of the Agency's objectives.
-
08 December 2009 /News - miscellaneous
Alternative practitioners must know regulations on health foods
If your company sells food supplements and/or medicines or if you import them from abroad, the products and your company must be registered with or authorised by the Danish authorities -
-
06 November 2009 /News - miscellaneous
The Danish Medicines Agency and the Danish Veterinary and Food Administration complete joint control of five sports stores
The Danish Medicines Agency and the Danish Veterinary and Food Administration complete joint control og five sports stores.
-
01 October 2009 /News - miscellaneous
Information regarding medicines containing dibutyl phthalate
The Danish Medicines Agency is presently reviewing which medicines containing dibutyl phthalate (DBP) are still on the Danish market.
-
14 May 2009 /News - miscellaneous
Medicines and weight loss
A number of medicines are available on the market for the treatment of life-threatening obesity. Most of these products are sold on prescription, but just recently a new medicine called Alli® was launched for over-the-counter sale.
